Evidence map›Paper›PMID 42219499›Full record

ArticleInfectious diseases of poverty2026

Repurposing GeneXpert® for rapid diagnosis of HPV-associated anal cancer: a case report of an unusually large lesion.

Livia Bresciani, Jacqueline Concha-Jaimes, Alonso Díaz-Sheen, Jorge Miguel Sabina-Vela, Heidy Sanchez, Manuel Rojas-Blasquez, Kristopher Pinto, Paolo Vassalini, Cesar Johnny Ramal-Asayag

Abstract readCase Reports
In one paragraph

Article in Infectious diseases of poverty, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Livia BrescianiSapienza University of Rome, Rome, Italy. livbresc@gmail.com.ORCID http://orcid.org/0009-0006-5297-225X
Jacqueline Concha-JaimesDepartment of Infectious Diseases and Tropical Medicine, Hospital Regional de Loreto, Iquitos, Peru.
Alonso Díaz-SheenDepartment of Medical Oncology, Hospital Regional de Loreto, Iquitos, Peru.
Jorge Miguel Sabina-VelaDepartment of Radiology, Hospital Regional de Loreto, Iquitos, Peru.
Heidy SanchezSchool of Medicine, Universidad Nacional de La Amazonía Peruana (UNAP), Iquitos, Peru.
Manuel Rojas-BlasquezDepartment of Infectious Diseases and Tropical Medicine, Hospital Regional de Loreto, Iquitos, Peru.
Kristopher PintoDepartment of Infectious Diseases and Tropical Medicine, Hospital Regional de Loreto, Iquitos, Peru.
Paolo VassaliniSapienza University of Rome, Rome, Italy.
Cesar Johnny Ramal-AsayagDepartment of Infectious Diseases and Tropical Medicine, Hospital Regional de Loreto, Iquitos, Peru.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundHuman papillomavirus (HPV)-associated anal squamous cell carcinoma (SCC) is strongly linked to persistent infection with high-risk HPV genotypes, particularly in people living with human immunodeficiency virus (HIV), who experience higher rates of viral persistence and oncogenic progression. The burden of HPV-related malignancies is disproportionately higher in low-resource settings, where limited access to screening, histopathology, and specialist care contributes to delayed diagnosis and advanced-stage presentation. In such contexts, rapid molecular diagnostic tools may help overcome diagnostic delays and support earlier clinical decision-making. CASE PRESENTATION: We describe an atypically presenting HPV-associated anal squamous cell carcinoma in a man living with HIV from the Peruvian Amazon, a region characterized by geographic and structural barriers to healthcare access. The patient presented with a large exophytic perianal lesion measuring 16 × 7 × 4 cm

conclusionsThis case highlights the potential utility of tissue-based GeneXpert HPV testing as a rapid adjunctive diagnostic tool in resource-limited settings where access to histopathology is delayed. Early molecular identification of high-risk HPV may support timely clinical decision-making and facilitate linkage to care. However, its clinical impact remains constrained in the context of advanced disease at presentation, underscoring the importance of addressing structural barriers to early diagnosis and sustained HIV and cancer care in underserved regions.

Indexed as

Anus NeoplasmsCarcinoma, Squamous CellHuman papillomavirus 16Papillomavirus InfectionsHIV InfectionsHumansMaleMiddle AgedMolecular Diagnostic TechniquesPeruAnal cancerGeneXpert®HIVHPV-16Low-resource settingsMolecular diagnostics

Identifiers

PMID42219499
PMCPMC13224515

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.